Resmed (RMD) Operating Margin (2009 - 2026)

Resmed has reported Operating Margin for 18 years, with the latest figure at 34.92% in Q1 2026.

• For the quarter ending Q1 2026, Operating Margin rose 192.0% year-over-year to 34.92%; the trailing twelve-month figure through Mar 2026 stood at 34.18% (up 207.0% YoY), and the FY2025 full-year result was 32.75%, up 458.0% from the prior year.
• Operating Margin for Q1 2026 stood at 34.92%, up from 34.56% in the prior quarter.
• The five-year high for Operating Margin was 34.92% in Q1 2026, with the low at 23.66% in Q4 2023.
• Historically, Operating Margin has averaged 29.93% across 5 years, with a median of 31.17% in 2024.
• Annual changes were most pronounced in 2023 — Operating Margin slumped 345 bps — and 2024, when it soared 889 bps.
• Resmed's Operating Margin stood at 27.1% in 2022, then dropped by 13 bps to 23.66% in 2023, then soared by 38 bps to 32.54% in 2024, then advanced by 6 bps to 34.56% in 2025, then grew by 1 bps to 34.92% in 2026.
• The last three Operating Margin figures came in at 34.92% (Q1 2026), 34.56% (Q4 2025), and 33.43% (Q3 2025), per Business Quant data.